Synergy research: Vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling

Phytomedicine

Volumn 16, Issue 1, 2009, Pages 2-16

  Ulrich Merzenich, Gudrun ^a   Zeitler, Heike ^a   Vetter, Hans ^a   Kraft, Karin ^b  

^a UNIVERSITY OF BONN   (Germany)

^b Clinic and Policlinic for Neurology   (Germany)

Author keywords

Antioxidants; Atherosclerosis; Cell signaling; Reactive oxygen species; Redox homeostasis

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; EPIGALLOCATECHIN GALLATE; ESCIN; GINKGO BILOBA EXTRACT; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; SELENIUM; TROXERUTIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DIETARY INTAKE; ELECTRON TRANSPORT; GENE EXPRESSION; HEART PROTECTION; HOMEOSTASIS AND REGULATION; HUMAN; INNATE IMMUNITY; INNER EAR; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; PHAGOCYTE; PHYTOTHERAPY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TEA; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; CELL SURVIVAL; DIETARY SUPPLEMENTS; FLAVONOIDS; HOMEOSTASIS; HUMANS; MAP KINASE SIGNALING SYSTEM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHENOLS; PHYTOTHERAPY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 58149392842     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.11.007     Document Type: Article

References (116)

1. Abe J., and Berk B.C. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc. 8 (1998) 59-64
2. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (ATBC). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330 (1994) 1029-1035
3. Anter E., Chen K., Shapira O.M., Karas R.H., and Keaney J.F. p38 Mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor α-dependent pathway in response to black tea polyphenols. Circ. Res. 96 (2005) 1072-1078
4. Azzi A. Molecular mechanism of α-tocopherol action. Free Radical Biol. Med. 43 (2007) 16-21
5. Babu P.V., and Liu D. Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 15 18 (2008) 1840-1850
6. Basu A., and Lucas E.A. Mechanism and effects of green tea on cardiovascular health. Nutr. Rev. 65 8 (2007) 361-375
7. Bell R.M., Cave A.C., Johar S Hearse D.J., Sha A.M., and Shattock M.J. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J. 19 (2005) 2037-2039
8. Benzie I.F. Vitamin C: prospective functional marker for defining optimal nutritional status. Proc. Nutr. Soc. 58 2 (1999) 469-476
9. Biesalski H.K. Vitamine. In: Biesalski H.K., Fürst P., Kasper H., Kluthe R., Pölert W., Puchstein C., and Stähelin H.B. (Eds). Ernährungsmedizin. second ed (1995), Thieme Verlag, Stutgard 44
10. Bleys J., Miller E.R., Pastor-Barriuso R., Appel L.J., and Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 84 (2006) 880-887
11. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., et al. Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomised placebo controlled trial. Lancet 356 (2000) 1213-1218
12. Böhm F., Settergren M., and Pernow J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin in humans in vivo. Atherosclerosis 190 2 (2007) 408-415
13. 2-induced apoptotic cell death via ERK activation. J. Neurochem. 76 (2001) 910-918
14. Brigelius-Flohé, and Davies K.J.A. Is vitamin E an antioxidant, a regulator of signal transduction and gene expression, or a "junk" food? Comments on the two accompanying papers: "Molecular mechanism of α-tocopherol action" by A. Azzi and "Vitamin E, antioxidant and nothing more" by M. Traber and J. Atkinson. Free Radic. Biol. Med. 43 (2007) 2-3
15. Brown A.A., and Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am. J. Clin. Nutr. 73 4 (2001) 673-686
16. Brown B.G., Zhao X.Y., Chait A., Fisher L.D., Cheung M.C., Morse J.S., et al. Simvastatin and niacin, antioxidant vitamins or the combination for prevention of coronary disease. N. Engl. J. Med. 345 (2001) 1583-1592
17. Cherubini A., Vigna G.B., Zuliania G., Ruggiero C., Senin U., and Gellin R. Role of antioxidants in atherosclerosis: epidemiological and clinical update. Curr. Pharm. Des. 11 6 (2005) 2017-2032
18. Collaborative Group of the Primary Prevention Project (PPP). Low dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 357 (2001) 89-95
19. Day A.J., Bao Y.P., Morgan M.R.A., and Williamson G. Conjugation position of quercetin glucuronides and effects on biological activity. Free Radical Biol. Med. 29 (2000) 1234-1243
20. DGE, 2000. Deutsche Gesellschaft für Ernährung, Österreichische Gesellschaft für Ernährung, Schweizerische Gesellschaft für Ernährung, Schweizerische Vereinigung für Ernährung (Hrsg.). Umschau/Braus, Referenzwerte für die Nährstoffzufuhr, Frankfurt am Main, pp. 137-144.
21. Dhalla N.S., Elmoselhi A.B., Hata T., and Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc. Res. 47 (2000) 446-456
22. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
23. Duthie S.J., Collins A.R., and Duthie G.G. The role of carotinoids in modulating DNA-stability and lipid peroxidation. Subcell. Biochem. 30 (1998) 181-207
24. Fang J.C., Kinlay S., Beltrama J., et al. Effect of vitamins C and E on progression of transplant-associated arterosclerosis: a randomised trial. Lancet 359 (2002) 1108-1113
25. Feng R., Lu Y., Bowman L.L., Qian Y., Castranova V., and Ding M. Inhibition of activator protein-1, NF-kB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. (2005) 27888-27895
26. Frankel E.N., and Finley J.W. How to standardize the multiplicity of methods to evaluate natural antioxidants. J. Agric. Food Chem. 56 (2008) 4901-4908
27. Frick M., and Weidinger F. Endothleial function: a surrogate endpoint in cardiovascular studies?. Curr. Pharm. Des. 13 17 (2007) 1741-1750
28. Fridovich I. The biology of oxygen radicals. Science 201 (1978) 875-880
29. Fuhr U., and Kummer A.L. The fate of nariginin in humans: a key to grapefruit juice-drug interactions. Clin. Pharmacol. Ther. 58 4 (1995) 365-373
30. Gey K.F. Vitamins E plus C and interacting nutrients required for optimal health. Biofactors 7 (1998) 113-174
31. Gianello R., Libinaki R., Azzi A., et al. Alpha-tocopheryl phosphate: a novel, natural form of vitamin E. Free Radical Biol. Med. 39 (2005) 970-976
32. GISSI-prevention Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results to the GISSI-prevention trial. Lancet 354 (1999) 447-455
33. Granado-Serrano A.B., Martin M.A., Bravo L., Goya L., and Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J. Nutr. 136 (2006) 2715-2721
34. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86 (2000) 494-501
35. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 186 (1990) 1-85
36. Hodis H.N., Mack W.J., LaBree L., et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atheroslcerosis Prevention Study (VEAPS). Circulation 106 (2002) 1453-1459
37. Hou D.X., Guo D., Tanigawa S., Hashimoto F., Uto T., Masuzaki S., Fujii M., and Sakata Y. Prodelphinidin B-4 3′-O-gallate, a tea polyphenol, is involved in the inhibition of COX-2 and iNOS via downregulation of TAK1-NF-kappaB pathway. Biochem. Pharmacol. 74 5 (2007) 742-751
38. Jackson S.H., Devadas S., Kwon J., Pinto L.A., and Williams M.S. T cells express a phagocyte-type NADPH oxidase that is activated after T Cell receptor stimulation. Nat. Immunol. 5 (2004) 818-827
39. Janisch K.M., Williamson G., Needs P., and Plumb G.W. Properties of quercetin conjugates: modulation of LDL oxidation and binding to human serum albumin. Free Radical Res. 38 8 (2004) 877-884
40. Kim M., Murakami A., Kawabata K., and Ohigshi H. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HAT-29 human colorectal cancer cells. Carcinognesis 26 9 (2005) 1553-1562
41. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., and Williamson G. How should we assess the effects of exposure to dietary pheonols in vitro?. Am. J. Clin. Nutr. 80 (2004) 15-21
42. Kwon O.S., Han J.H., Yoo H.G., Chung J.H., Cho K.H., Eun H.C., and Kim K.H. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCF). Phytomedicine 14 7-8 (2007) 551-555
43. Kyaw M., Yoshizumi M., Tsuchiya K., Izawa Y., Kanematsu Y., and Tamaki T. Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol. Sin. 25 8 (2004) 977-985
44. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 2 (2001) 807-869
45. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160
46. Lee J.S., Oh Ty., Kim Y.K., Baik J.H., So S., Hahm K.B., and Surh Y.J. Protective effects of green tea polyphenol extracts against ethanol-induced gastric mucosal damages in rats: stress-responsive transcription factors and MAP kinases as potential targets. Mutat. Res. 579 1-2 (2005) 214-224
47. Lee K.W., Kundu J.K., Kim S.O., Lee H.J., and Surh Y.J. Cocoa polyphenold inhibit phorbol Ester-induced superoxide anion formation in cultured HL-60 cells and expression of cyclooxygenase-2 and activation of NF-kB and MAPKs in mouse skin in vivo. J. Nutr. 136 (2006) 1150-1155
48. Levine M., Dariwal K.R., Welch R.W., Wang Y., and Park J.B. Determination of optimal Vitamin C requirements in humans. Am. J. Clin. Nutr. 62 6 Suppl. (1995) 1347S-1356S
49. Levine M., Padayatty S., Wang Y., et al. Vitamin C. In: Stipanik M.H. (Ed). Biochemical and Physiological Aspects of Human Nutrition. second ed. (2006), WB Saunders Company, St. Louis 760-796
50. Li J., Stouffs M., Serrander L., Banfi B., Bettiol E., Charmay Y., Steger K., Kraise K.H., and Jacone M.E. The NADPH oxidase NOX drives cardiac differentiation: role in regulating cardiac transcription factor and MAP kinase activation. Mol. Biol. Cell 17 (2006) 3978-3988
51. Lichtenstein A.H., Appel L.J., Brands M., Carnethon M., Daniels S., Harold A., and Franch H.A. Diet and lifestyle recommendations revision: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114 (2006) 82-96
52. Liu W., Schoenkermann A., and Lowe Jr. W.L. Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 279 4 (2000) E782-E790
53. Lonn E.M., Yusuf S., Dzavik V., et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103 (2001) 915-925
54. Manach C., Williamson G., Morand C., Sclabert A., and Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81 suppl. (2005) 230S-242S
55. Metzner C., and Ulrich-Merzenich G. Arginin und Taurin-präventive Nahrungsfaktoren bei kardiovaskulären Erkrankungen?. Ernährungs-Umschau 48 (2001) 188-192
56. Meydani S., Meydani M., Blumberg J., et al. Vitamin E supplementation and in vivo immune response in healthy elderly: a randomized controlled trial. JAMA 277 (1997) 1380-1386
57. Morris C.D., and Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidences for the U.S. Preventive Services Task Force. Ann. Int. Med. 139 (2003) 56-71
58. MRC/BHD Heart Protection Study Collaborative Group. Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
59. MRC/BHF. Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 23-33
60. Muntwyler J., Hennekens C.H., Manson J.E., Buring J.E., and Gaziano J.M. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch. Intern. Med. 162 (2002) 1472-1476
61. Negis Y., Zingg J.M., Ogru E., Gianello R., Libinaki R., and Azzi A. On the existence of cellular tocopheryl phosphate, its synthesis, degradation and cellular roles: a hypothesis. JUBMB Life 57 (2005) 23-25
62. Negis Y., Aytan N., Ozer N., Ogru E., Lbinakir R., Gianello R., Azzi A., and Zingg J.M. The effect of tocopheryl phosphates on atherosclerosis progression in rabbits fed with high cholesterol diet. Arch. Biochem. Biophys. 450 (2006) 63-66
63. Nicolls M.R., Haskins K., and Flores S. Oxidant stress, immune dysregulation and vascular function in type I diabetes. Antiox. Redox. Signal. 9 7 (2007) 879-889
64. Nunes G.L., Robinson K., Kalynych A., King III S.B., Sgoutas D.S., and Berk B.C. Vitamins C and E inhibit superoxidradical production in the pig coronary artery. Circulation 96 (1997) 3593-3601
65. Oak M.H., Chataigneau M., Keravis T., Chataigneau T., Beretz A., Andriantsitohaina R., Stoclet J.C., Chang S.J., and Schini-Kerth V.B. Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of p38 mitogen-activated protein kinase pathway. Arterioscler. Thromb. Vasc. Biol. 23 6 (2003) 1001-1007
66. AB-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br. J. Phamacol. 149 (2006) 283-290
67. Okamoto M., and Uens Y. Is sudden death with vitamin C deficiency caused by a lack of carnitin?. J. Clin. Forensic Med. 13 1 (2006) 26-29
68. Patel R., Krishnan R., Ramchandran A., and Maru G. Polymeric black tea polyphenols inhibit mouse skin chemical carcinogenesis by decreasing cell proliferation. Cell Prolif. 41 3 (2008) 532-553
69. Pervaiz S., and Clement M.V. Superoxide anion: oncogenic reactive oxygen species?. Int. J. Biochem. Cell Biol. 39 (2007) 1297-1304
70. Pi X., Yan C., and Berk B.C. Big mitogen-activated protein kinase (BMK1)/ERK5 protects endothelial cells from apoptosis. Cir. Res. 94 3 (2004) 362-369
71. Polychronopoulus E., Zeimbekis A., Kastorini C.M., Papairaklerous N., Vlachou I., Bountziouka V., and Panagiotakos D.B. Effect of black and green tea consumption on blood glucose levels in non-obese elderly men and women from Mediterranean Islands (MEDIS epidemiological study). Eur. J. Nutr. 47 1 (2008) 10-16
72. Qin F., Shite J., and Liang C.S. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHG: association with changes in MAPK pathways. AJP-Heart 285 (2003) 822-832
73. Regan C.P., Li W., Boucher D.M., Spatz S., Su M.S., and Kuida K. Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc. Natl. Acad. Sci. USA 99 14 (2002) 9248-9253
74. Richards G.A., Therona A.J., Van Rensburg C.E., et al. Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers. Am. Rev. Respir. Dis. 142 (1990) 648-654
75. Rimm E.B., Willett WC Hu F.B., Sampson L., Colditz G.A., Manson J.E., et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279 (1998) 359-364
76. Rodrigo R., Guichard C., and Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam. Clin. Pharmacol. 21 2 (2007) 111-127
77. Salonen J.T., Nyyssonen K., and Salonen R. Antioxidant supplement in atheroslcerosis prevention (ASAP) study: a randomised trial of the effect of vitamin E and C on 3-years progression of carotid atherosclerosis. J. Intern. Med. 248 (2000) 377-386
78. Salonen R.M., Nyyssonen K., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Rissanen T.H., et al. Six-year effect of combined vitamin C and E supplementation on atheosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107 (2003) 947-953
79. Sato Y., Hagiwara K., Arai H., and Inoue K. Purification and characterization of the alpha-tocopherol transfer protein from rat liver. FEBS Lett. 288 (1991) 41-45
80. Sauer H., Wartenberg M., and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol. Biochem. 11 (2001) 173-186
81. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutri. 130 (2000) 2073S-2085S
82. Schmelter M., Ateghang B., Helmig S., Wartenber M., and Sauer H. Embryonic stem cells utilize reactive oxygen species as transducers of mechanical strain-induced cardiovascular differentiations. FASEB J. 20 (2006) 1182-1184
83. Shi H., Noguchi N., and Niki E. Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroqinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radical Biol. Med. 27 (1999) 334-346
84. Siekmeier R., Steffen C., and Marz W. Can antioxidants atherosclerosis?. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49 10 (2006) 1034-1049
85. Siegers C.P., Syed Ali S., and Tegtmeier M. Aescin and troxerutrin as a successful combination for the treatment of inner ear perfusion disturbance. Phytomedicine 15 3 (2008) 160-163
86. Singleton V.L., and Rossi J.A.J. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16 (1965) 144-158
87. Stadtman E.R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62 (1993) 797-821
88. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., and Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328 (1993) 1444-1449
89. Stephens N.G., Parsons A., and Schofield P. Randomised controlled trial of vitamin E in patients with coronary artery disease. CHAOS. Lancet 347 (1996) 781-786
90. Tantcheva L.P., Stoeva E.S., Galabov A.S., Braykova A.A., Savov V.M., and Mileva M.M. Effect of vitamin E and vitamin C combination on experimental influenza virus infection. Methods Find. Exp. Clin. Pharmacol. 25 4 (2003) 259-264
91. Traber M.G., and Atkinson J. Vitamin E, antioxidant and nothing more. Free Radical Biol. Med. 43 1 (2007) 4-15
92. Ulker S., Mc Keown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
93. Ulrich-Merzenich G., Metzner C., Schiermeyer B., and Vetter H. Vitamin C and E antagonistically modulate human vascular endothelial and smooth muscle cell DNA synthesis and proliferation. Eur. J. Nutr. (2002) 27-34
94. Ulrich-Merzenich G., Metzner C., Bhonde R.R., Malsch G., Schiermeyer B., and Vetter H. Simultaneous isolation of endothelial and smooth muscle cells from human umbilical artery or vein and their growth response to low density lipoproteins. In Vitro Cell Dev. Anim. 38 (2002) 265-272
95. Ulrich-Merzenich G., Zeitler H., Panek D., Bokemeyer D., and Vetter H. Vitamin C activates the ERK-signaling pathway. Eur. J. Nutr. 46 (2007) 87-94
96. Ulrich-Merzenich G., Zeitler H., Jobst J., Panek D., Vetter H., and Wagner H. Application of the "omic"-technologies in phytomedicine. Phytomedicine 14 (2007) 70-82
97. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., and Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39 1 (2007) 44-84
98. Van het Hof K.H., de Boer H.S., Wiseman S.A., Lien N., Westrate J.A., and Tijburg L.B. Consumption of green or black tea does not increase resistance of low density lipoprotein to oxidation in humans. Am. J. Clin. Nutr. 66 5 (1997) 1125-1132
99. Van Tits L.J., de Waart F., Hak-Lemmers H.L., et al. Effects of alpha-tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radical Biol. Med. 30 (2001) 1122-1129
100. Venardos K.M., Perkins A., Headrick J., and Kaye D.M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr. Med. Chem. 14 (2007) 1539-1549
101. Virtamo J., Rapola J.M., Ripatti S., Heinonen O.P., Taylor P.R., Albenes D., et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch. Intern. Med. 158 (1998) 668-675
102. Wagner H. Multitarget therapy-the future treatment for more than just functional dyspepsia. Phytomedicine 13 (2006) 122-129
103. Watanabe S., Yamaguchi M., Sobue T., Takahashi T., Miaura T., Arai Y., Mazur W., Wähälä K., and Adlercreutz H. Pharmacokinectics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (Kinako). J. Nutr. 128 (1998) 1710-1715
104. Waters D.D., Alderman E.L., Hsia J., et al. (WAVE) Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA 288 (2002) 2432-2440
105. Webb A.L., and Villamor E. Update: effects of antioxidant and non-antioxidant vitamin supplementation on immune function. Nutr. Rev. 65 (2007) 181-217
106. Whitehead T.P., Robinson D., Allaway S., Syms J., and Hale A. Effects of red wine ingestion on the antioxidant capacity of serum. Clin. Chem. 41 (1995) 32-35
107. Williamson G., and Manach C. Bioavailability and bioefficacy of polyphenols in humans II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81 (2005) 243S-255S
108. Williamson G., and Manach C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 93 intervention studies. Am. J. Clin. Nutr. 81 suppl. (2005) 243S-255S
109. Wollin M.S., Ahmad M., and Gupte S.A. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am. J. Physiol. Lung Cell Mol. Physiol. 289 (2005) L159-L173
110. Wu Y., Li S., Cui W., Zu X., Du J., and Wang F. Gingko biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium dependent vasodilatation. Phytomedicine 15 3 (2008) 164-169
111. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Moon J.H., Terao J., and Tamaki T. Quercetin glucuronid prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem. Biophys. Res. Commun. 293 5 (2002) 1458-1465
112. Yoshizumi M., Tsuchiya K., and Tamaki T. Signal transduction of reactive oxygen species and mitogen activated protein kinases in cardiovascular disease. J. Med. Invest. 48 1-2 (2001) 11-24
113. Yoshizumi M., Tsuchiya K., Suzaki Y., Kirima K., Kyaw M., Suzaki Y., and Tamaki T. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol. Pharmacol. 60 (2001) 656-665
114. Young J.F., Nielson S.E., Haraldsdottir J., Daneshvar B., Laurdisen S.T., Knuthsen P., Crozier A., Sandstrom B., and Dargsted L.O. Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am. J. Clin. Nutr. 69 (1999) 87-94
115. Yusuf S., Dagenais G., and Pogue J. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study investigators. N. Engl. J. Med. 342 (2000) 154-160
116. Zureik M., Galan P., Bertrais S., et al. Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries. Arteroscler. Thromb. Vasc. Biol. 24 (2004) 1485-1491